# S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

> **NCT00100789** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 67 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** gemcitabine
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00100789
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2012-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100789, "S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00100789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*